Cargando…
Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient‐Derived Xenograft Models
BACKGROUND AND AIMS: Hepatoblastoma (HBL) is a devastating pediatric liver cancer with multiple treatment options, but it ultimately requires surgery for a cure. The most malicious form of HBL is a chemo‐resistant aggressive tumor that is characterized by rapid growth, metastases, and poor response...
Autores principales: | Johnston, Michael Edward, Rivas, Maria Prates, Nicolle, Delphine, Gorse, Aurore, Gulati, Ruhi, Kumbaji, Meenasri, Weirauch, Matthew T., Bondoc, Alexander, Cairo, Stefano, Geller, James, Tiao, Gregory, Timchenko, Nikolai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463483/ https://www.ncbi.nlm.nih.gov/pubmed/34037269 http://dx.doi.org/10.1002/hep.31919 |
Ejemplares similares
-
Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin
por: D’Souza, Amber M., et al.
Publicado: (2021) -
HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer
por: Rivas, Maria, et al.
Publicado: (2021) -
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma
por: Gulati, Ruhi, et al.
Publicado: (2022) -
β‐catenin cancer–enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma
por: Gulati, Ruhi, et al.
Publicado: (2022) -
Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma
por: Bondoc, Alexander, et al.
Publicado: (2021)